TITLE

Proximal Tibial Osteochondromas in Patients with Fibrodysplasia Ossificans Progressiva

AUTHOR(S)
Deirmengian, Gregory K.; Hebela, Nader M.; O'Connell, Michael; Glaser, David L.; Shore, Eileen M.; Kaplan, Frederick S.
PUB. DATE
February 2008
SOURCE
Journal of Bone & Joint Surgery, American Volume;Feb2008, Vol. 90-A Issue 2, p366
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Fibrodysplasia ossificans progressiva is a rare autosomal dominant disorder characterized by congenital malformation of the great toes and by progressive heterotopic ossification of skeletal muscle and soft connective tissues. The disorder is caused by a recurrent missense mutation in the glycine-serine activation domain of activin A receptor type I, a bone morphogenetic protein (BMP) type-I receptor, in all classically affected individuals. Osteochondromas of the proximal part of the tibia are benign osteochondral neoplasms or orthotopic lesions of skeletal remodeling associated with dysregulated BMP signaling and have been considered an atypical feature of fibrodysplasia ossificans progressiva, but they may be underdiagnosed because of their often asymptomatic nature. The purpose of the present study was to determine the prevalence and characteristics of proximal tibial osteochondromas in individuals who have fibrodysplasia ossificans progressiva. Methods: Over a period of thirty months, we evaluated all patients with new and established fibrodysplasia ossificans progressiva for the presence of proximal tibial osteochondromas on the basis of medical history, physical examination, and radiographic studies. We quantified the prevalence of osteochondromas and characterized the types of osteochondromas to identify relevant trends. Results: Ninety-six patients (including fifty-two female patients and forty-four male patients) with fibrodysplasia ossificans progressiva were evaluated on the basis of a history and physical examination. Plain radiographs were available for sixty-seven patients. Ninety percent of all patients had osteochondroma of the proximal part of the tibia. These lesions usually were asymptomatic, most commonly were bilateral, and typically were located at the pes anserinus. Seventy-five percent of the lesions were pedunculated, and 25% were sessile. Conclusions: Proximal tibial osteochondromas are a common phenotypic feature of fibrodysplasia ossificans progressiva, a finding that expands the recognized consequences of recurrent activating mutations in activin A receptor type I to include not only congenital skeletal malformations and heterotopic skeletogenesis but also benign osteochondral neoplasms or orthotopic lesions of skeletal modeling. The present study provides insight into the genetic basis of osteochondroma formation in patients with fibrodysplasia ossificans progressiva and possibly into that of more common conditions in which these lesions occur.
ACCESSION #
30000049

 

Related Articles

  • Fibrodysplasia ossificans progressiva: a case report. Önal, Merih; Bajin, M. Demir; Yılmaz, Taner // Turkish Journal of Pediatrics;Sep/Oct2014, Vol. 56 Issue 5, p561 

    Fibrodysplasia ossificans progressiva (FOP) is a rare, severely disabling, autosomal dominant disease characterized by recurrent painful episodes of soft tissue swelling and the development of heterotopic ossification. The main target is the axial musculature, but eventually ectopic bone...

  • Developmental biology: Blood-vessel cells turn to bone.  // Nature;11/25/2010, Vol. 468 Issue 7323, p479 

    The article focuses on research regarding the mutation in the Alk2 gene of patients with fibrodysplasia ossificans progressiva (FOP), which results to the formation of bone in soft tissues and the endothelial cells.

  • Building bone from blood vessels. Horwitz, Edwin M. // Nature Medicine;Dec2010, Vol. 16 Issue 12, p1373 

    In this article the author discusses the study conducted by D. Medici and colleagues concerning the mesenchymal stem cells (MSCs) source on people with fibrodysplasia ossificans progressiva (FOP). He says that the study provided cues that could be used in cell therapy for treating people who...

  • Functional Modeling of the ACVR1 (R206H) Mutation in FOP. Jay Groppe // Clinical Orthopaedics & Related Research;Sep2007, Vol. 462 Issue 1, p87 

    Individuals with fibrodysplasia ossificans progressiva are born with malformations of the great toes and develop a heterotopic skeleton during childhood because of an identical heterozygous mutation in the glycine-serine activation domain of ACVR1, a bone morphogenetic protein type I receptor....

  • Early Mortality and Cardiorespiratory Failure in Patients with Fibrodysplasia Ossificans Progressiva. Kaplan, Frederick S.; Zasloff, Michael A.; Kitterman, Joseph A.; Shore, Eileen M.; Hong, Charles C.; Rocke, David M. // Journal of Bone & Joint Surgery, American Volume;Mar2010, Vol. 92-A Issue 3, p686 

    Background: Fibrodysplasia ossificans progressiva, a rare genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification in humans. However, little is known about the lifespan or causes of mortality in these patients. We undertook this study to...

  • Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review. LAKKIREDDY, MAHESHWAR; CHILAKAMARRI, VIJAYKRISHNA; RANGANATH, PRAJNYA; ARORA, ABHISHEK JAGDISHCHANDER; VANAJA, MARIA CELESTINA // Journal of Clinical & Diagnostic Research;Aug2015, Vol. 9 Issue 8, p1 

    Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformation of the great toes and disabling heterotopic ossification in specific anatomic locations with a world wide prevalence of 1 in 2 million population. Nearly 90% of patients with FOP are...

  • Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis. Lounev, Vitali Y.; Ramachandran, Rageshree; Wosczyna, Michael N.; Yamamoto, Masakazu; Maidment, Andrew D. A.; Shore, Eileen M.; Glaser, David L.; Goldhamer, David J.; Kaplan, Frederick S. // Journal of Bone & Joint Surgery, American Volume;Mar2009, Vol. 91-A Issue 3, p652 

    Background: Individuals who have fibrodysplasia ossificans progressiva develop an ectopic skeleton because of genetic dysregulation of bone morphogenetic protein (BMP) signaling in the presence of inflammatory triggers. The identity of progenitor cells that contribute to various stages of...

  • THE MYSTERY OF THE SECOND SKELETON. ZIMMER, CARL // Atlantic;Jun2013, Vol. 311 Issue 5, p72 

    The article discusses genetic research on fibrodysplasia ossificans progressiva (FOP), and describes the contributions of the research to more common bone diseases such as osteoporosis. FOP patient Jeannie Peeper's founding of FOP societies and efforts to seek FOP research funding are discussed,...

  • Treating Toe Pain, Kill the Nerve?  // Running & FitNews;Jul/Aug2009, Vol. 27 Issue 4, p25 

    The article presents an answer to a question on how to treat toe pain.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics